This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Coronary Heart Disease
and you are
over 18
years old
The phase for this study is not defined.
Show me locations

The purpose

Study on the registration of coronary heart disease patients undergoing PCI in Chinese's population. Get the incidence of adverse events in these patients after PCI, a clear type of adverse reaction, forms, influencing factors, to establish risk management processes, clinical safety and reasonable treatment, and provide the basis for further research and reference.

Provided treatments

  • Drug: antiplatelet agents(Clopidogrel or Ticagrelor)

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02888652. The sponsor of the trial is The Third Xiangya Hospital of Central South University and it is looking for 1500 volunteers for the current phase.
Official trial title:
Multivariate Analysis of Platelet Reactivity Variety in Patients With Coronary Heart Disease After PCI